#USA #New York #Class Action #Gross Law Firm #Hims & Hers

Overview

Hims & Hers Health, Inc. is currently embroiled in a class action lawsuit, which has drawn considerable attention from shareholders. The Gross Law Firm has issued an important announcement intended for investors who purchased shares during the specified class period from April 29, 2025, to June 23, 2025. This legal action centers around allegations that Hims & Hers Health engaged in deceptive practices and made misleading statements that could have affected stock prices and investor decisions.

Allegations

The lawsuit alleges that during the listed class period, Hims & Hers issued false or misleading statements regarding their business practices. Specifically, the allegations include that the company was involved in "deceptive promotion and selling of illegitimate, knockoff versions of Wegovy®"—a product that raises significant concerns regarding patient safety. As a result of these actions, there exists a substantial risk that the partnership with Novo Nordisk could be terminated, subsequently leading to losses for the shareholders.

Shareholder Action

The Gross Law Firm encourages all shareholders who purchased shares within the class period to contact them to discuss the potential for becoming a lead plaintiff. Importantly, registering as a lead plaintiff is not a prerequisite for participating in any recovery from this lawsuit. All affected investors should ensure they register their information promptly due to the looming deadline of August 25, 2025, to seek lead plaintiff status.

As part of the process, registered shareholders will be enrolled in a portfolio monitoring system, designed to keep them informed of the case’s progress and provide status updates throughout the litigation process. This measure is intended to empower investors by keeping them directly connected to the case developments.

Next Steps

Investors are urged not to delay in their registration to ensure that they are not left out of this potential recovery line. The Gross Law Firm emphasizes that participation in this case involves no financial obligation or costs to the shareholders, reinforcing the firm’s commitment to protecting investor rights against fraudulent business practices.

The firm, recognized nationally for its adept handling of class action suits, aims to recover losses for shareholders who face the repercussions of Hims & Hers' actions. This case serves as a reminder of the importance of transparency and ethical practices within the corporate domain, as misleading information can significantly impact stock performance and shareholder investments.

Contact Information

For further inquiries, interested shareholders can reach out to The Gross Law Firm, located at 15 West 38th Street, 12th floor, New York, NY, 10018. They can also be contacted via email at [email protected] or by phone at (646) 453-8903 for additional assistance and information concerning the lawsuit.

Conclusion

As the situation surrounding Hims & Hers Health, Inc. continues to develop, shareholders are advised to remain vigilant about their rights and the impact of corporate actions on their investments. This lawsuit represents a significant opportunity for shareholders to join forces and seek accountability and recovery from alleged corporate misconduct.